AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04717895 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Rocking environment forward (B) followed by a translation environment
Description: Start by the virtual reality session by viewing a rocking environment followed by a translation environment
Study NCT04717895 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Translation environment followed by a rocking environment
Description: Start by the virtual reality session by viewing a translation environment followed by a rocking environment
Study NCT05894772 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Power over Pain Portal
Description: Youth from different ages, sexes, gender, sexual orientations, races, dwelling and school/employment status will receive access to the Power over Pain Portal for 4 months. The portal consists of self-assessment tools (bi-weekly check-ins to provide users with feedback on their mood, anxiety, pain, and sleep and guide decision making on choice of interventions), evidence-based virtual educational (pain neuroscience) and cognitive behavioural therapy (CBT) pain interventions that are delivered in a stepped care manner based on participant needs/preference. The overall objective is to determine the implementation (guided by Proctor's implementation conceptual framework) and clinical effectiveness of the PoP Portal in a sample of youth (12-18 years of age) who are on the waitlist for tertiary care consultation at any pediatric CP clinic in Canada.
Study NCT04157075 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: Bupivicaine injection into uterosacral ligaments prior to colpotomy
Study NCT04157075 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Bupivacaine
Description: Bupivicaine injection into uterosacral ligaments prior to colpotomy
Study NCT04157075 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Bupivacaine
Description: Bupivicaine injection into uterosacral ligaments prior to colpotomy
Study NCT05379231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: BiCROS fitting
Description: Each participant will be fitted with the experimental CROS device on the unaidable ear and with a compatible hearing aid on the other ear.
Study NCT05379231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Monaural hearing aid fitting
Description: Each participant will be fitted with a hearing aid on the better hearing ear and no device on the unaidable ear.~Monaural hearing aid fitting acts as control intervention.
Study NCT05379231 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Unaided condition
Description: No treatment, i.e. the participants are not fitted with a CROS device and/ or hearing aid.~Unaided condition acts as control intervention.
Study NCT05888194 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mucogyne® gel
Description: In Mucogyne group, each eligible patient will receive a box of Mucogyne® gel. The patient will apply Mucogyne® gel, 48-hours after delivery, everyday, twice a day, massaging it into the intimate area, for a 10-day period.
Study NCT06242093 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: whole body vibrator
Description: • WBVT and Conservative treatment Group A will receive WBVT with conservative treatment. The treatment will be given with the frequency of 34 times/week for 25-30 minutes with the help of Galileo vibration platform
Study NCT06242093 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: GROUP B Pelvic floor muscle training (PFMT) and conservative treatment.
Description: Pelvic floor muscle training (PFMT) and conservative treatment.~Group B will receive (PFMT) with conservative treatment. The PMFT group will be educated to do each exercise in 3-4 set with 15-20 repetitions and a 60-second relax between each set.~Time: 3-4 Times/WEEK for 8 weeks
Study NCT05589740 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Culturally tailored healthy eating advice
Description: Culturally-tailored education includes strategies for healthy eating, preferences for traditional healthy foods, recommendations for limiting unhealthy traditional foods, portion sizes, etc.
Study NCT05589740 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard healthy eating advice
Description: Standard healthy eating education includes strategies, foods, portions, and cooking and eating tips for general dietary recommendations from USDA My Plate
Study NCT05616845 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Picterus Jaundice Pro
Description: Use Picterus Jaundice Pro, a smartphone app that is used to take photo of the newborns skin, where the Picterus calibration card is place.
Study NCT05264636 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sucrose
Description: Sucrose Beverage
Study NCT05264636 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Steviol Glycosides
Description: Steviol Glycoside Beverage
Study NCT06148350 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stroke Rehabilitation
Description: Both the groups received interventions three days/week for 30-60 minutes for four weeks
Study NCT06148350 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stroke Rehabilitation
Description: Both the groups received interventions three days/week for 30-60 minutes for four weeks
Study NCT05587608 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: combined thoracic segmental spinal epidural anesthesia
Description: ultrasound guided thoracic segmental spinal anesthesia at the level of T10 interlaminar space , patients will be in sitting position, spinal needle is then introduced through the epidural needle not more than 0.5 cm beyond the Dura matter. 2cc of heavy Marcaine plus 25 ug fentanyl are injected through the spinal needle.
Study NCT04544124 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingency management
Description: Incentives will be provided for treatment attendance over a 12-week period.
Study NCT05481970 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dexmedetomidine,ketamine,lidocaine,propofol
Description: Group (A): Induction of general anesthesia will be done using lidocaine (1.5 mg/kg), propofol (2-3 mg/kg), and atracurium (0.5 mg/kg). Dexmedetomidine 0.5 µg/kg over 10 min, started 10 min before induction. Following tracheal intubation, dexmedetomidine infusion generally will be initiated at 0.6 μg/kg/h and titrated between 0.2 and 1.0 μg/kg/h according to the heart rate maintaining bispectral index (BIS) between 40-60, lidocaine (1.5 mg/kg/h). ketamine will be given as a bolus dose of 0.3 mg/kg after induction and prior to skin incision then 0.2 mg/kg/h as an infusion. Patients will receive dexamethasone (8 mg i.v.) after induction.
Study NCT05481970 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: fentanyl,propofol
Description: In group (B) for induction of anesthesia, patients will receive propofol 2-3mg/kg, fentanyl 1-2mcg/kg and atracurium 0.5 mg/kg as a muscle relaxant to facilitate intubation. Fentanyl bolus doses of 0.5-1 mcg/kg will be given to keep BIS score 40-60 during surgery.
Study NCT06293950 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: WJMSC
Description: - Patients receive three intravenous doses of MSCs (1 million/kg) every two weeks as treatment.
Study NCT05254652 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Duloxetine 30mg
Description: Case management consists confirmation of hospital visit date, checking the adverse effect and treatment compliance.
Study NCT05254652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duloxetine 30mg
Description: Case management consists confirmation of hospital visit date, checking the adverse effect and treatment compliance.
Study NCT05254652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pregabalin 150mg
Description: Case management consists confirmation of hospital visit date, checking the adverse effect and treatment compliance.
Study NCT04961476 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: 1-MNA
Description: 1-MNA supplementation
Study NCT04846972 — intervention group
Intervention type: BEHAVIORAL
Intervention: FASTRACS intervention
Description: Intervention (4 steps) :~* Penultimate to last chemotherapy : patient will receive tools of the intervention~* 1 month after the end of oncological treatment (OT): patient will attend a general medicine consultation with the GP RTW checklist~* 2 months after OT: patient will attend a pre RTW visit with the OP RTW checklist~* 5 months after the end of OT: if the patient has not returned to work 10 months after inclusion, they will have a visit with an OP-RTW to work coordinator~Self-questionnaires will evaluate quality of life (EORTC QLQC30, BR23, Euroqol (EQ-5D-5L)), anxiety and depression (HAD), employment status, self-efficacy to return to work (RTW-SE11), pre-RTW and RTW visit with the OP, social support, care consumption, physical activity (short IPAQ), perceived performance (WRF), work conditions. The implementation and use of the intervention tools will also be assessed: the patient guide, the employer guide, RTW checklists for the GP and the OP.
Study NCT04716010 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Participants will complete a shopping task in the online grocery store, and the products that contain red meat will not have warning labels or a 30% increase in price.
Study NCT04716010 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Warning Labels
Description: While completing the shopping task in the online grocery store, the health and environmental warning labels will appear next to the image of every product that contains red meat.
Study NCT04716010 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tax
Description: While completing the shopping task in the online grocery store, all products containing red meat will have a 30% increase in price.
Study NCT04716010 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Combined Warning Labels and Tax
Description: While completing the shopping task in the online grocery store, all products containing red meat will have the health and environmental warning labels appear next to the product image and a 30% increase in price.
Study NCT04624672 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Semaglutide (1 Mg Dose)
Description: Weekly injection of study drug for 4-6 months prior to Roux-en-Y gastric bypass surgery
Study NCT04624672 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Weekly injection of placebo for 4-6 months prior to Roux-en-Y gastric bypass surgery
Study NCT05480501 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: IM19 CAR-T cells
Description: IM19 CAR-T cells administrated in a dosage to be selected by physician from a specific range.
Study NCT06092086 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Loratinib
Description: Continuous daily PO dosing of lorlatinib 100mg QD.
Study NCT05478538 — intervention group
Intervention type: PROCEDURE
Intervention: Core Needle or Forceps Biopsy
Description: Subjects must be clinically able, at investigator discretion, to undergo additional core needle or forceps biopsy passes during their biopsy. These additional biopsies may either be collected from the primary tumor or a metastatic site amenable to additional passes (e.g., liver or lymph nodes) per the clinician.
Study NCT04917120 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: The procedure will consist of a virtual reality program associated with suggestions of hypnoanalgesia, be added to usual care. Included patients will benefit from the Virtual Reality program combined with hypnoanalgesia suggestions for a period of 20 minutes. We will use a helmet with a built-in screen and an audio headset connected to a control room. Patients will watch an Virtual Reality sequence while listening to narratives designed for the hypnoanalgesia of the present pain.
Study NCT05827718 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Method of Contact
Description: Behavioral Intervention studied here is the method of contact (text vs. email vs. email+text).
Study NCT05827718 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Source of Contact
Description: Behavioral Intervention studied here is source of contact (personal clinic vs. research team)
Study NCT05827718 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Framing Method (Appeal to Altruism or Social Proof
Description: Behavioral Intervention studied here is the framing methods appeal to altruism and social proof
Study NCT05827718 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Incentive Structure
Description: Behavioral Interventions studied here are guaranteed vs. lottery incentives
Study NCT04920175 — intervention group
Intervention type: OTHER
Intervention: Novel Real-time Neonatal Sleep Stage Detection Algorithm
Description: Comparison of Novel Real-time Neonatal Sleep Stage Detection Algorithm to gold standard concurrent polysomnogram.
Study NCT05272657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: low-carbohydrate diet
Description: subjects in this arm are given detailed instructions and coaching in following a low-carbohydrate diet.
Study NCT05272657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Description: subjects in this arm are given detailed instructions and coaching in following a Mediterranean diet.
Study NCT05673889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ARV-471
Description: Experimental
Study NCT05673889 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate
Description: Probe substrate
Study NCT05154071 — intervention group
Intervention type: OTHER
Intervention: Collection of medical data
Description: Collection of adverse events, of mortality, length of hospitalization
Study NCT06506292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: Adebrelimab:1200 mg, iv, d1
Study NCT06506292 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XELOX
Description: oxaliplatin: 130 mg/m2,iv,d1; capecitabine: 1000 mg/m2,po,pid,d1-d14
Study NCT05177289 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Theradome® LH80 pro
Description: The Theradome LH80 pro is a wearable laser helmet device, which uses red laser light to stop hair loss, thicken existing hair and stimulate the growth of new hair.
Study NCT05177289 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Scalp cooling
Description: Scalp cooling is a standard treatment that is applied to prevent hair loss during chemotherapy.
Study NCT05177289 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Scalp cooling
Description: Scalp cooling is a standard treatment that is applied to prevent hair loss during chemotherapy.
Study NCT06066606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vilanterol and Fluticasone Furoate (low dose)
Description: Participants are administered 25 µg of vilanterol + fluticasone furoate
Study NCT06066606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vilanterol and Fluticasone Furoate (high dose)
Description: Participants are administered 100 µg of vilanterol + fluticasone furoate
Study NCT06066606 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants are administered placebo
Study NCT06153199 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-management videos
Description: Short video modules on self-management of back pain without medication and ergonomic adjustments for limiting back pain in nursery and landscape work
Study NCT06153199 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-management videos
Description: Short video modules on self-management of back pain without medication and ergonomic adjustments for limiting back pain in nursery and landscape work
Study NCT06153199 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Check lists for ergonomic options
Description: Guidance on ergonomic choices appropriate for work tasks not currently being used that are the most difficult due to back pain, using a checklist
Study NCT06153199 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Text reminders
Description: Reminders to implement choices using graphics and gifs as well as motivational messages
Study NCT06153199 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video review
Description: Participants will review videos of their movement during their most difficult work tasks to help problem solving to adjust ergonomic adjustments
Study NCT05543733 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home exercise program
Description: Participants will complete a 6-month prescription telemedicine-based structured home exercise program. Baseline information will be used to develop a personalized home exercise program. This program will involve downloading the MyDataHelps application on a mobile device to securely collect wearable device information like step counts, activity minutes, and heart rate. Additionally, participants will have multiple virtual visits as well as the 2 in-person visits.
Study NCT05986591 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Test Product - Tiotropium Bromide Inhalation Powder 18 mcg
Description: Test Product
Study NCT05986591 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Spiriva Handihaler (Tiotropium Bromide) 18 mcg
Description: RLD
Study NCT05986591 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Product
Study NCT04689555 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Novel method without manual compression
Description: Novel method for femoral artery hemostasis without manual compression. After sheath removal, four or five sterile gauzes were overlaid layer by layer and then bandaged without the procedure of manual compression.
Study NCT05457400 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ENSO 16
Description: 30 g ENSO 16 dissolved in Water
Study NCT05457400 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Glucose Powder
Description: 30 g Glucose Powder dissolved in Water
Study NCT04689555 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard method with manual compression.
Description: Standard method for femoral artery hemostasis with manual compression.After sheath removal, manual compression was continued for at least 10 minutes or until hemostasis. After that four or five sterile gauzes were overlaid layer by layer and then bandaged without the procedure of manual compression.
Study NCT06396065 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AK112 Injection
Description: Subjects will receive AK112 Plus Pemetrexed and Carboplatin via intravenous infusion (IV) Q3W, up to 4 cycles. Afterward, AK112 Plus Pemetrexed will be used for maintenance treatment (administered on Day 1 of each cycle, Q3W) up to 2 years.
Study NCT06396065 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo Injection
Description: Subjects will receive Placebo Plus Pemetrexed and Carboplatin via intravenous infusion (IV) Q3W, up to 4 cycles in treatment periods per the randomization schedule. Afterward, Placebo Plus Pemetrexed will be used for maintenance treatment (administered on Day 1 of each cycle, Q3W) up to 2 years.
Study NCT05428540 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich supplement
Description: Polyphenol-rich capsules containing 1,200 mg of a combination of plant extracts rich in polyphenols. Frequency: 3 capsules a day. Duration: 12 weeks.
Study NCT05428540 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05843617 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Liposomal Vitamin C
Description: 1000 mg of ascorbic acid in liposomal formulation
Study NCT05843617 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Traditional Vitamin C
Description: 1000 mg of ascorbic acid in traditional formulation
Study NCT06266871 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SOX+Tislelizumab+LDRT
Description: All patients will start with one cycle of neoadjuvant therapy of SOX plus tislelizumab regimen: S-1: 40-60 mg Bid, d1-14, q3w; oxaliplatin: 130 mg/m2, iv drip, d1, q3w; tislelizumab: 200 mg, iv drip, d1, q3w.~LDRT will be performed in the target area. After radiotherapy, patients will receive another two cycles of SOX plus tislelizumab.~Radical D2 gastric cancer resection will be performed 4-6 weeks after the last administration of SOX plus tislelizumab.~The adjuvant therapy will start in 4-6 weeks after the surgery, and we recommend adjuvant treatment with SOX regimen for up to 5 cycles.
Study NCT06450223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Perampanel 12 MG
Description: 1 tablet of Perampanel Tablets 12 mg
Study NCT06450223 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fycompa 12 mg film-coated tablets
Description: 1 tablet of Perampanel Tablets 12 mg